| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J0178 |
Aflibercept injection |
3,256 |
2,808 |
$1.36M |
| 67028 |
|
6,629 |
5,563 |
$793K |
| J2777 |
Inj, faricimab-svoa, 0.1mg |
522 |
446 |
$229K |
| 92134 |
|
9,184 |
8,762 |
$94K |
| 92201 |
|
5,886 |
5,351 |
$55K |
| 92014 |
|
4,710 |
4,622 |
$55K |
| 92226 |
|
3,435 |
1,677 |
$49K |
| 99215 |
Prolong outpt/office vis |
708 |
636 |
$38K |
| 99214 |
|
1,826 |
1,795 |
$31K |
| J9035 |
Bevacizumab injection |
239 |
163 |
$18K |
| J7999 |
Compounded drug, noc |
662 |
591 |
$14K |
| J2778 |
Ranibizumab injection |
30 |
25 |
$11K |
| 99233 |
Prolong inpt eval add15 m |
220 |
144 |
$9K |
| J0177 |
Inj, aflibercept hd, 1 mg |
16 |
13 |
$9K |
| 92235 |
|
536 |
530 |
$6K |
| 99205 |
Prolong outpt/office vis |
177 |
177 |
$6K |
| 92202 |
|
395 |
351 |
$4K |
| 4177F |
|
3,002 |
2,634 |
$3K |
| 92250 |
|
253 |
249 |
$3K |
| 99223 |
Prolong inpt eval add15 m |
24 |
24 |
$2K |
| 92225 |
|
162 |
84 |
$2K |
| 99204 |
|
17 |
17 |
$66.42 |
| G8756 |
No bp measure doc |
488 |
420 |
$0.00 |
| G9903 |
Pt scrn tbco id as non user |
5,002 |
4,417 |
$0.00 |
| G8397 |
Dil macula/fundus exam/w doc |
1,299 |
1,133 |
$0.00 |
| G8428 |
Cur meds not document |
1,639 |
1,498 |
$0.00 |
| 1036F |
|
5,546 |
4,949 |
$0.00 |
| 2022F |
|
1,566 |
1,368 |
$0.00 |
| 2024F |
|
1,561 |
1,357 |
$0.00 |
| G8427 |
Docrev cur meds by elig clin |
4,222 |
4,020 |
$0.00 |
| 5010F |
|
1,310 |
1,139 |
$0.00 |
| G9744 |
Pt not eli d/t act dig htn |
3,610 |
3,250 |
$0.00 |
| 2026F |
|
1,558 |
1,354 |
$0.00 |
| G8785 |
Bp scrn no perf at interval |
44 |
37 |
$0.00 |